Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR‑188‑3p and regulating GPX4 expression

Li,Zhongjun; Luo,Yi; Wang,Chunbo; Han,Dunxin; Sun,Weiping

doi:10.3892/or.2023.8629

Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR‑188‑3p and regulating GPX4 expression

Authors:
- Zhongjun Li
- Yi Luo
- Chunbo Wang
- Dunxin Han
- Weiping Sun
View Affiliations

Affiliations: Department of Orthopaedics, Weihai Medical District of The 970th Hospital of The PLA Joint Logistic Support Force, Weihai, Shandong 264200, P.R. China, Department of Orthopaedics, The 970th Hospital of The PLA Joint Logistic Support Force, Yantai, Shandong 264002, P.R. China
Published online on: September 14, 2023 https://doi.org/10.3892/or.2023.8629
Article Number: 192
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As a newly identified circular RNA (circRNA), the role of circBLNK in cancer progression has not been probed. The objective of the present study was to functionally dissect the role of circBLNK in osteosarcoma (OS) tumorigenesis and progression. With regards of the experimental procedure, the levels of mRNAs and proteins were assessed using reverse transcription‑quantitative PCR and western blot analysis, respectively. The subcellular location of circBLNK in OS cells was determined by cell cytosolic/nuclear fractionation assay. Cell ferroptosis ability was assessed through MTT assay. Cell proliferative abilities were assessed by clonogenic and Cell Counting Kit‑8 assays, and cell apoptosis was measured using flow cytometry. The relationships among circBLNK, miR‑188‑3p, and glutathione peroxidase 4 (GPX4) were validated by luciferase reporter and RNA pull‑down assays, as well as RNA immunoprecipitation. The stability of circBLNK and linear BLNK was confirmed using RNase R treatment assay. The association between circBLNK expression and overall survival rate was assessed by Kaplan‑Meier plot. The correlation between the expression levels of circBLNK, miR‑188‑3p, and GPX4 in OS tissues was assessed by Pearson's χ² test. The results revealed that CircBLNK and GPX4 were significantly upregulated in OS tissues, which predicted the poor prognosis. CircBLNK knockdown led to suppressed cell proliferation and enhanced cell apoptosis, an effect that could be reversed by the inhibition of miR‑188‑3p. In an in vivo circBLNK deficiency model, tumor growth was observed to be markedly suppressed. Moreover, circBLNK deficiency elevated levels of intracellular free iron (Fe²⁺), malondialdehyde, lipid reactive oxygen species and mitochondrial superoxide, while diminishing mitochondrial membrane potential in Erastin‑treated OS cells, which were eliminated by overexpressing GPX4. Furthermore, mechanistic investigations revealed that circBLNK sponged miR‑188‑3p to regulate the expression of GPX4, thereby affecting OS progression. In conclusion, the present study delineated a new regulatory axis involving circBLNK/miR‑188‑3p/GPX4 in OS progression, adding to the growing evidence that circRNAs are critical gene regulators in cancer progression.

View Figures

View References

1	Noone AM, Cronin KA, Altekruse SF, Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar : PubMed/NCBI
2	Rainusso N, Wang LL and Yustein JT: The adolescent and young adult with cancer: State of the Art-bone tumors. Curr Oncol Rep. 15:296–307. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
4	Bishop MW, Janeway KA and Gorlick R: Future directions in the treatment of osteosarcoma. Curr Opin Pediatr. 28:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
5	Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P and Kaghazian M: Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 18:1582018. View Article : Google Scholar : PubMed/NCBI
6	Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
7	Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019. View Article : Google Scholar : PubMed/NCBI
8	Li J, Sun D, Pu W, Wang J and Peng Y: Circular RNAs in cancer: Biogenesis, function, and clinical significance. Trends Cancer. 6:319–336. 2020. View Article : Google Scholar : PubMed/NCBI
9	Liu Z, Liu F, Wang F, Yang X and Guo W: CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 476:175–186. 2021. View Article : Google Scholar : PubMed/NCBI
10	Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L, Mo Y, Li X, Guo C, Zhang S, et al: CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett. 496:41–56. 2021. View Article : Google Scholar : PubMed/NCBI
11	Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI
12	Li C, Tian Y, Liang Y and Li Q: Retraction note to: Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int. 21:4162021. View Article : Google Scholar : PubMed/NCBI
13	Li ZQ, Wang Z, Zhang Y, Lu C, Ding QL, Ren R, Cheng BB and Lou LX: CircRNA_103801 accelerates proliferation of osteosarcoma cells by sponging miR-338-3p and regulating HIF-1/Rap1/PI3K-Akt pathway. J Biol Regul Homeost Agents. 35:1021–1028. 2021.PubMed/NCBI
14	Gong G, Han Z, Wang W, Xu Q and Zhang J: Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375. Cell Cycle. 19:2139–2147. 2020. View Article : Google Scholar : PubMed/NCBI
15	Liu DY, Li Z, Zhang K, Jiao N, Lu DG, Zhou DW, Meng YB and Sun L: Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis. Eur Rev Med Pharmacol Sci. 25:86–93. 2021.PubMed/NCBI
16	Thomson DW and Dinger ME: Endogenous microRNA sponges: Evidence and controversy. Nat Rev Genet. 17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
17	Zheng S, Jiang F, Ge D, Tang J, Chen H, Yang J, Yao Y, Yan J, Qiu J, Yin Z, et al: LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother. 112:1086952019. View Article : Google Scholar : PubMed/NCBI
18	Zhang W, Li JZ, Tai QY, Tang JJ, Huang YH and Gao SB: LncRNA DANCR regulates osteosarcoma migration and invasion by targeting miR-149/MSI2 axis. Eur Rev Med Pharmacol Sci. 24:6551–6560. 2020.PubMed/NCBI
19	Xu M, Zhang YY, Wang HF and Yang GS: The expression and function of miRNA-106 in pediatric osteosarcoma. Eur Rev Med Pharmacol Sci. 21:715–722. 2017.PubMed/NCBI
20	Luo Z, Fan Y, Liu X, Liu S, Kong X, Ding Z, Li Y and Wei L: MiR-188-3p and miR-133b suppress cell proliferation in human hepatocellular carcinoma via post-transcriptional suppression of NDRG1. Technol Cancer Res Treat. 20:153303382110330742021. View Article : Google Scholar : PubMed/NCBI
21	Pei J, Zhang S, Yang X, Han C, Pan Y, Li J, Wang Z, Sun C and Zhang J: Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling. RNA Biol. 18 (Suppl 1):S287–S302. 2021. View Article : Google Scholar
22	Pei J, Zhang J, Yang X, Wu Z, Sun C, Wang Z and Wang B: TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p. Cancer Cell Int. 19:752019. View Article : Google Scholar : PubMed/NCBI
23	Seiler A, Schneider M, Förster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, et al: Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8:237–248. 2008. View Article : Google Scholar : PubMed/NCBI
24	Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
25	Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171:273–285. 2017. View Article : Google Scholar : PubMed/NCBI
26	Xu Z, Chen L, Wang C, Zhang L and Xu W: MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4. Free Radic Res. 55:1119–1129. 2021. View Article : Google Scholar : PubMed/NCBI
27	Liu Q and Wang K: The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int. 43:1245–1256. 2019. View Article : Google Scholar : PubMed/NCBI
28	Issue Information-declaration of Helsinki. J Bone Miner Res. 34:BM i–BM ii. 2019.
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
30	Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, Zhang L and Chen J: The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 19:732020. View Article : Google Scholar : PubMed/NCBI
31	Xu L, Duan J, Li M, Zhou C and Wang Q: Circ_0000253 promotes the progression of osteosarcoma via the miR-1236-3p/SP1 axis. J Pharm Pharmacol. 75:227–235. 2023. View Article : Google Scholar : PubMed/NCBI
32	Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P and Wu M: CircRNA: Functions and properties of a novel potential biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
33	Wang D, Yang S, Wang H, Wang J, Zhang Q, Zhou S, He Y, Zhang H, Deng F, Xu H, et al: The progress of circular RNAs in various tumors. Am J Transl Res. 10:1571–1582. 2018.PubMed/NCBI
34	Yang Y, Yujiao W, Fang W, Linhui Y, Ziqi G, Zhichen W, Zirui W and Shengwang W: The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biological Res. 53:402020. View Article : Google Scholar
35	Patop IL, Wüst S and Kadener S: Past, present, and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI
36	Chen Z, Xu W, Zhang D, Chu J, Shen S, Ma Y, Wang Q, Liu G, Yao T, Huang Y, et al: circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression. Mol Ther Nucleic Acids. 23:1120–1135. 2021. View Article : Google Scholar : PubMed/NCBI
37	Guan K, Liu S, Duan K, Zhang X, Liu H, Xu B, Wang X and Jin X: Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression. Aging (Albany NY). 13:25484–25495. 2021. View Article : Google Scholar : PubMed/NCBI
38	Lin E, Liu S, Xiang W, Zhang H and Xie C: CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218. Biomed Res Int. 2020:83869362020. View Article : Google Scholar : PubMed/NCBI
39	Meng L, Jiang YP, Zhu J and Li B: MiR-188-3p/GPR26 modulation functions as a potential regulator in manipulating glioma cell properties. Neurol Res. 42:222–227. 2020. View Article : Google Scholar : PubMed/NCBI
40	Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, et al: Genome-Wide miRNA analysis identifies miR-188-3p as a novel prognostic marker and molecular factor involved in colorectal carcinogenesis. Clin Cancer Res. 23:1323–1333. 2017. View Article : Google Scholar : PubMed/NCBI
41	Gao F, Han J, Wang Y, Jia L, Luo W and Zeng Y: Circ_0109291 promotes cisplatin resistance of oral squamous cell carcinoma by sponging miR-188-3p to increase ABCB1 expression. Cancer Biother Radiopharm. 37:233–245. 2022.PubMed/NCBI
42	Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH: An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI
43	Hassannia B, Vandenabeele P and Vanden Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell. 35:830–849. 2019. View Article : Google Scholar : PubMed/NCBI
44	Chen X, Kang R, Kroemer G and Tang D: Broadening horizons: The role of ferroptosis in cancer. Nat Rev Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
45	Liang C, Zhang X, Yang M and Dong X: Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 31:e19041972019. View Article : Google Scholar : PubMed/NCBI
46	Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R and Tang D: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
47	Lei T, Qian H, Lei P and Hu Y: Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Cancer Sci. 112:4785–4798. 2021. View Article : Google Scholar : PubMed/NCBI
48	Luo Y, Gao X, Zou L, Lei M, Feng J and Hu Z: Bavachin induces ferroptosis through the STAT3/P53/SLC7A11 axis in osteosarcoma cells. Oxid Med Cell Longev. 2021:17834852021. View Article : Google Scholar : PubMed/NCBI